OneAscent Wealth Management LLC acquired a new position in shares of Shockwave Medical, Inc. (NASDAQ:SWAV – Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 665 shares of the company’s stock, valued at approximately $217,000.
A number of other institutional investors have also added to or reduced their stakes in SWAV. HighTower Advisors LLC lifted its holdings in Shockwave Medical by 24.9% during the 3rd quarter. HighTower Advisors LLC now owns 2,500 shares of the company’s stock worth $501,000 after purchasing an additional 498 shares in the last quarter. Envestnet Portfolio Solutions Inc. purchased a new stake in Shockwave Medical during the 3rd quarter worth about $204,000. Envestnet Asset Management Inc. lifted its holdings in Shockwave Medical by 85.2% during the 3rd quarter. Envestnet Asset Management Inc. now owns 37,533 shares of the company’s stock worth $7,473,000 after purchasing an additional 17,271 shares in the last quarter. Hsbc Holdings PLC lifted its holdings in Shockwave Medical by 47.8% during the 3rd quarter. Hsbc Holdings PLC now owns 1,119 shares of the company’s stock worth $223,000 after purchasing an additional 362 shares in the last quarter. Finally, Treasurer of the State of North Carolina increased its stake in Shockwave Medical by 0.4% in the 3rd quarter. Treasurer of the State of North Carolina now owns 16,390 shares of the company’s stock worth $3,263,000 after acquiring an additional 60 shares during the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.
Shockwave Medical Stock Performance
Shares of NASDAQ SWAV opened at $334.75 on Friday. The stock has a market cap of $12.57 billion, a price-to-earnings ratio of 78.21, a P/E/G ratio of 2.43 and a beta of 0.88. The company has a current ratio of 13.81, a quick ratio of 12.61 and a debt-to-equity ratio of 0.97. Shockwave Medical, Inc. has a 1-year low of $157.00 and a 1-year high of $334.90. The stock’s 50-day moving average is $332.60 and its 200 day moving average is $279.46.
Wall Street Analysts Forecast Growth
SWAV has been the topic of a number of research analyst reports. CL King restated a “neutral” rating on shares of Shockwave Medical in a research note on Monday, April 8th. Leerink Partnrs lowered Shockwave Medical from an “outperform” rating to a “market perform” rating in a research note on Friday, April 5th. Needham & Company LLC restated a “hold” rating on shares of Shockwave Medical in a research note on Friday, April 5th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a $335.00 target price (up from $270.00) on shares of Shockwave Medical in a research note on Monday, April 8th. Finally, Piper Sandler upped their target price on Shockwave Medical from $290.00 to $360.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 2nd. Ten research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, Shockwave Medical has a consensus rating of “Hold” and an average price target of $309.11.
Check Out Our Latest Analysis on SWAV
Shockwave Medical Profile
Shockwave Medical, Inc, a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels.
Featured Articles
- Five stocks we like better than Shockwave Medical
- How to Capture the Benefits of Dividend Increases
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- Where to Find Earnings Call Transcripts
- MarketBeat Week in Review – 6/24 – 6/28
- How to Most Effectively Use the MarketBeat Earnings Screener
- General Mills Stock Drops After Revenue Miss in Fiscal Q4 2024
Receive News & Ratings for Shockwave Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shockwave Medical and related companies with MarketBeat.com's FREE daily email newsletter.